Latest news
Clene Announces Biomarker Analyses To Be Included in NDA Submission Supporting ALS Accelerated Approval - Investing News NetworkInvesting News Network · Mon, 10 Aug 2026 23:23:09 GMTClene (CLNN) ties CNM-Au8 ALS survival gains to NfL biomarker for planned NDA - Stock TitanStock Titan · Mon, 10 Aug 2026 12:08:13 GMTXENE: Azetukalner NDA on track for Q3 2026; strong cash position supports ongoing late-stage trials - TradingViewTradingView · Thu, 06 Aug 2026 20:18:52 GMTSTOK: Phase 3 enrollment complete for zorevunersen; NDA submission and strong cash runway support 2028 launch - TradingViewTradingView · Mon, 03 Aug 2026 20:12:01 GMT